Market Moves
ONWARD Medical's spinal stimulator sales stalled in the third quarter
ONWARD Medical reported EUR 2.5 million of revenue for the third quarter of 2026 on 3 November, up from EUR 1.7 million a year earlier, but ARC-EX product revenue of EUR 2.0 million and 88 units were roughly level with the second quarter. The shares closed about 11.5 per cent lower in Brussels and KBC Securities cut its rating to hold.